53 filings
6-K
ACHL
Achilles Therapeutics Plc
17 May 24
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
5:15pm
6-K
ACHL
Achilles Therapeutics Plc
8 May 24
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
7:44am
S-8
ACHL
Achilles Therapeutics Plc
4 Apr 24
Registration of securities for employees
8:25am
6-K
ACHL
Achilles Therapeutics Plc
13 Nov 23
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
4:36pm
6-K
uoewwmzhmwyvoa58w9
22 Sep 23
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
4:42pm
6-K
qydnyo95nb90ej5k
4 Aug 23
Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
7:42am
6-K
4ue2kfes gw3oj31zh
29 Jun 23
Current report (foreign)
4:03pm
6-K
zvyc fojf539n
10 May 23
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
8:46am
6-K
y1nvlotlm ezzd5
24 Apr 23
Current report (foreign)
5:02pm
S-8
uxkcb2zlr5vs
8 Mar 23
Registration of securities for employees
8:04am
EFFECT
3bmzlohyfoy mpuecj
18 Nov 22
Notice of effectiveness
12:15am
CORRESP
tf54oyfyocxhf1zorly
15 Nov 22
Correspondence with SEC
12:00am
UPLOAD
btrrk9
14 Nov 22
Letter from SEC
12:00am
F-3
7v7s4qhm8lxd 3iul4
8 Nov 22
Shelf registration (foreign)
9:28am
6-K
4lws7i ykcm6bjgvhee
8 Nov 22
Achilles Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
8:21am
6-K
i0j4bq
9 Aug 22
Achilles Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
12:00am
6-K
1c14yo
28 Jun 22
Current report (foreign)
4:03pm
6-K
k2p442j1banzs5
26 May 22
Current report (foreign)
6:15am